PATENT CLAIM ANALYSIS

Application Number: 16282817
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["514", "454000"]

Abstract:
Oral cannabinoid formulations, including an aqueous-based oral dronabinol solution, that are stable at room or refrigerated temperatures and may possess improved in vivo absorption profiles with faster onset and lower inter-subject variability.

Claim (Index 1):
A stable oral pharmaceutical solution comprising from about 0.1% to about 5% w/w of dronabinol, 33% w/w or less water, from about 15 to about 95% w/w alcohol and from about 5 to about 21% w/w of a co-solvent consisting of propylene glycol, polyethylene glycol or a mixture thereof and an antioxidant, wherein w/w denotes weight by total weight of the solution.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 99.0
- Lexical Diversity: 1.06061
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15132896', '13222989', '13644283', '11299183', '10656304']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7645439239735277
- 35 USC 102 Novelty (BERT): 0.5100512546060907
- Combined Prediction Score: 0.739094657036784
- Mean Citation Score: 265.72394
- Max Citation Score: 313.5166
- Similarity Product: 279.80404856143

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test